Cyclic GMP-dependent Pathways Protect Differentiated Oligodendrocytes from Multiple Types of Injury
Overview
Authors
Affiliations
The cyclic GMP analog 8-bromo-cyclic GMP (8-Br-cGMP) protects differentiated murine oligodendrocytes (OLs) from caspase-mediated death initiated by staurosporine, thapsigargin or kainate. Caspase-independent death caused by high levels of NO is also partially prevented by 8-Br-cGMP. Inhibitors of protein kinase G (cGMP-dependent protein kinase, cGK) reversed protection, supporting involvement of cGK. Since NO stimulates soluble guanylate cyclase, increasing cGMP, we treated OLs with low levels of NO and observed partial protection against thapsigargin, staurosporine and kainate. Two inhibitors of mitochondrial pore transition (MPT), cyclosporin A and bongkrekic acid, were poorly protective, indicating that cGMP is not acting primarily by blocking MPT. 8Br-cGMP was more effective than 8Br-cAMP in protecting against staurosporine or release of intracellular Ca(++) by thapsigargin. The cAMP analog exhibited little or no protection against kainate or high levels of NO. Thus cGK signaling is more effective than protein kinase A or phosphodiesterase 3 signaling in preventing OL death.
The Emerging Role of Phosphodiesterase 5 Inhibition in Neurological Disorders: The State of the Art.
Crescioli C, Paronetto M Cells. 2024; 13(20.
PMID: 39451238 PMC: 11506759. DOI: 10.3390/cells13201720.
Rethinking of phosphodiesterase 5 inhibition: the old, the new and the perspective in human health.
Paronetto M, Crescioli C Front Endocrinol (Lausanne). 2024; 15:1461642.
PMID: 39355618 PMC: 11442314. DOI: 10.3389/fendo.2024.1461642.
The Role of Sildenafil in Treating Brain Injuries in Adults and Neonates.
Xiong Y, Wintermark P Front Cell Neurosci. 2022; 16:879649.
PMID: 35620219 PMC: 9127063. DOI: 10.3389/fncel.2022.879649.
Mechanisms Involved in the Remyelinating Effect of Sildenafil.
Diaz-Lucena D, Gutierrez-Mecinas M, Moreno B, Martinez-Sanchez J, Pifarre P, Garcia A J Neuroimmune Pharmacol. 2017; 13(1):6-23.
PMID: 28776122 DOI: 10.1007/s11481-017-9756-3.
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review.
Peixoto C, Dos Santos Gomes F J Inflamm (Lond). 2015; 12:54.
PMID: 26379476 PMC: 4570643. DOI: 10.1186/s12950-015-0099-7.